Search This Blog

Wednesday, October 3, 2018

Eidos Therapeutics granted orphan status for amyloidosis treatment


The FDA granted Eidos Therapeutics orphan status for its treatment of transthyretin amyloidosis.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)